NAD+ IV

NAD+ IV

Starting At

$250.00
Book Appointment

NAD+ IV Infusion is a restorative therapy that delivers nicotinamide adenine dinucleotide (NAD+), an essential coenzyme involved in cellular energy production, mitochondrial function, and DNA repair. NAD+ levels naturally decline with age, contributing to fatigue, cognitive decline, and reduced cellular resilience. By replenishing NAD+ directly into the bloodstream over a slow two-hour infusion, this therapy enhances brain function, promotes healthy aging, and supports optimal cellular performance.

 


Product Details:

Form: Intravenous Infusion (2-hour slow administration)

Mechanism of Action: NAD+ serves as a critical coenzyme in redox reactions that generate ATP, the body’s primary energy source. It also activates DNA repair, gene expression, and cellular stress responses, making it central to both energy metabolism and longevity pathways.

Results: Clinical and experiential use has shown improved mental clarity, reduced fatigue, enhanced focus, and increased resilience against age-related cellular decline.

 


Product Benefits:

  • Restores declining NAD+ levels to support cellular health

  • Boosts mitochondrial energy production and reduces fatigue

  • Enhances brain function, focus, and mental clarity

  • Supports DNA repair and cellular resilience against stress

  • Promotes healthy aging by protecting against oxidative damage

  • Aids recovery after illness, high stress, or intensive physical exertion

 


Conditions That May Benefit Include:

  • Chronic fatigue and low energy states

  • Cognitive decline, brain fog, and memory difficulties

  • Age-related cellular dysfunction

  • Neurological conditions associated with oxidative stress

  • Recovery from illness or heavy training

  • Individuals seeking anti-aging or longevity support

 


Important Notes:

Side Effects: May include temporary flushing, cramping, or discomfort at the infusion site. Slow infusion minimizes adverse effects. Some individuals may feel lightheaded or fatigued immediately after treatment.

Contraindications: Patients with severe heart disease, renal impairment, or known hypersensitivity to NAD+ therapy should avoid treatment. Pregnant or breastfeeding individuals are not eligible for this treatment.